Abstract
The development of a useful Candida vaccine is a distinct possibility despite the fact that individuals with a lifetime of commensal sensitization do not develop sterile immunity to the organism. An effective Candida vaccine would be invaluable in preventing hematogenously disseminated candidiasis, as well as mucocutaneous disease. This review is a discussion of our current understanding of the interplay between commensal and pathogenic forms of Candida albicans and approaches toward active and passive immunoprevention against candidiasis.
This is the second of a series of reviews that detail the basic science progress in the quest to achieve vaccines for several of the medically important fungi.
This is the second of a series of reviews that detail the basic science progress in the quest to achieve vaccines for several of the medically important fungi.